• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在患者特异性树突状细胞免疫治疗中使用的黑色素瘤细胞对干扰素-γ促凋亡作用的抵抗与改善的总生存相关。

Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.

机构信息

Cell Biology Laboratory, Hoag Cancer Center, 1 Hoag Drive Bldg 41, 92663, Newport Beach, CA, USA.

出版信息

Cancer Immunol Immunother. 2011 Jan;60(1):123-31. doi: 10.1007/s00262-010-0925-y. Epub 2010 Oct 20.

DOI:10.1007/s00262-010-0925-y
PMID:20960187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11029524/
Abstract

The use of whole cell tumor vaccines and various means of loading antigen onto dendritic cells have been under investigation for over a decade. Induction of apoptosis and the exposure of immune-stimulating proteins are thought to be beneficial for the use in immunotherapy protocols, but conclusive evidence in the clinical setting has been lacking. Incubation of melanoma cell lines with interferon-gamma (IFN-γ) increased phosphatidylserine and calreticulin exposure, but not in the IFN-γ-resistant cell line Lu-1205. Short-term autologous melanoma cell lines used for loading dendritic cells for immunotherapy showed differential response to the pro-apoptotic effects of IFN-γ. These IFN-γ-treated tumor cells (TCs) were irradiated and used for loading antigen for dendritic cell therapy. A log-rank comparison of survival for patients whose TCs were found to be either sensitive (upregulated phosphatidylserine and calreticulin) or insensitive to IFN-γ revealed a strongly significant correlation to progression-free (p = 0.003) and overall survival (p = 0.002) favorably in those patients whose cell lines were resistant to the proapoptotic effect of IFN-γ. These results suggest that the use of IFN-γ in anti-melanoma dendritic cell-based immunotherapy may only be beneficial when the cells do not undergo apoptosis in response to IFN-γ and support the contention that the use of some apoptotic cells in vaccines may be detrimental.

摘要

十多年来,人们一直在研究使用全肿瘤细胞疫苗和各种方法将抗原加载到树突状细胞上。诱导细胞凋亡和暴露免疫刺激蛋白被认为有利于免疫治疗方案的应用,但在临床环境中缺乏确凿的证据。用干扰素-γ(IFN-γ)孵育黑色素瘤细胞系增加了磷脂酰丝氨酸和钙网蛋白的暴露,但在 IFN-γ 抗性细胞系 Lu-1205 中则没有。用于加载树突状细胞进行免疫治疗的短期自体黑色素瘤细胞系对 IFN-γ 的促凋亡作用表现出不同的反应。这些经 IFN-γ 处理的肿瘤细胞(TCs)经过照射,用于加载抗原用于树突状细胞治疗。对 TCs 被发现对 IFN-γ 敏感(上调磷脂酰丝氨酸和钙网蛋白)或不敏感的患者进行生存对数秩比较,结果显示对无进展(p=0.003)和总生存(p=0.002)有强烈的显著相关性,这对那些细胞系对 IFN-γ 的促凋亡作用具有抗性的患者有利。这些结果表明,在抗黑色素瘤树突状细胞为基础的免疫治疗中使用 IFN-γ 可能只有在细胞不因 IFN-γ 而发生凋亡时才有益,并支持在疫苗中使用一些凋亡细胞可能有害的观点。

相似文献

1
Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.在患者特异性树突状细胞免疫治疗中使用的黑色素瘤细胞对干扰素-γ促凋亡作用的抵抗与改善的总生存相关。
Cancer Immunol Immunother. 2011 Jan;60(1):123-31. doi: 10.1007/s00262-010-0925-y. Epub 2010 Oct 20.
2
Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.负载灭活同种异体黑色素瘤细胞的树突状细胞可诱导客观临床反应和MART-1特异性CD8 + T细胞免疫。
J Immunother. 2006 Sep-Oct;29(5):545-57. doi: 10.1097/01.cji.0000211309.90621.8b.
3
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial.用多种肿瘤抗原冲击的自体树突状细胞疫苗治疗恶性黑素瘤患者的Ⅰ/Ⅱ期试验结果。
Cytotherapy. 2010 Oct;12(6):721-34. doi: 10.3109/14653241003774045.
4
Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma.树突状细胞疫苗治疗播散性黑色素瘤患者的I/II期研究。
Cancer Immunol Immunother. 2004 Feb;53(2):125-34. doi: 10.1007/s00262-003-0429-0. Epub 2003 Nov 5.
5
Characterization of interferon-γ-treated melanoma tumor cells for use in dendritic cell-based immunotherapy.用树突状细胞为基础的免疫疗法对干扰素-γ处理的黑色素瘤肿瘤细胞进行特征分析。
Cancer Biother Radiopharm. 2011 Jun;26(3):345-51. doi: 10.1089/cbr.2011.0959. Epub 2011 Jun 28.
6
Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma.用于转移性黑色素瘤的树突状细胞疫苗的三种抗原加载方法。
Melanoma Res. 2018 Jun;28(3):211-221. doi: 10.1097/CMR.0000000000000441.
7
Long-Term Progression-Free and Overall Survival in Two Melanoma Patients Treated with Patient-Specific Therapeutic Vaccine Eltrapuldencel-T After Resection of a Solitary Liver Metastasis.
Cancer Biother Radiopharm. 2016 Apr;31(3):71-4. doi: 10.1089/cbr.2016.2003.
8
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate.用异源黑色素瘤细胞系裂解物脉冲处理的自体树突状细胞治疗生物化疗难治性IV期黑色素瘤患者的初步研究。
Cancer Immunol Immunother. 2004 Jul;53(7):651-8. doi: 10.1007/s00262-003-0495-3. Epub 2004 Mar 16.
9
Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.肿瘤干细胞抗原作为巩固性主动特异性免疫治疗:树突细胞与肿瘤细胞治疗转移性黑色素瘤的随机 II 期试验。
J Immunother. 2012 Oct;35(8):641-9. doi: 10.1097/CJI.0b013e31826f79c8.
10
Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma.晚期转移性黑色素瘤患者中与免疫治疗临床反应相关的免疫学特征。
Immunol Cell Biol. 2006 Jun;84(3):295-302. doi: 10.1111/j.1440-1711.2006.01445.x.

引用本文的文献

1
Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors.γ干扰素在黑色素瘤患者对免疫检查点抑制剂免疫治疗反应中的双重作用
Mol Cancer. 2025 Mar 20;24(1):89. doi: 10.1186/s12943-025-02294-x.
2
Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes.原肾素肽疫苗对 2 型糖尿病小鼠模型糖尿病视网膜病变早期的影响。
PLoS One. 2022 Jan 18;17(1):e0262568. doi: 10.1371/journal.pone.0262568. eCollection 2022.
3
Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants.暴露于物理等离子体衍生氧化剂后小鼠黑色素瘤中的毒性和免疫原性
Oxid Med Cell Longev. 2017;2017:4396467. doi: 10.1155/2017/4396467. Epub 2017 Jun 27.
4
Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.蛋白标志物与 AJCC 分期 III 期黑色素瘤患者的生存结局相关。
Pigment Cell Melanoma Res. 2014 Nov;27(6):1106-16. doi: 10.1111/pcmr.12290. Epub 2014 Aug 14.
5
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.聚肌胞诱导的肿瘤细胞死亡导致树突状细胞成熟和 Th1 激活。
Cancer Immunol Immunother. 2011 Nov;60(11):1609-24. doi: 10.1007/s00262-011-1058-7. Epub 2011 Jun 21.
6
Autologous peripheral blood mononuclear cell recognition of autologous proliferating tumor cells in the context of a patient-specific vaccine trial.在一项针对特定患者的疫苗试验背景下,自体外周血单个核细胞对自体增殖肿瘤细胞的识别。
J Biomed Biotechnol. 2011;2011:635850. doi: 10.1155/2011/635850. Epub 2011 Apr 26.

本文引用的文献

1
Establishment of stable cell lines for personalized melanoma cell vaccine.建立稳定的细胞系用于个体化黑素瘤细胞疫苗。
Melanoma Res. 2010 Aug;20(4):280-92. doi: 10.1097/CMR.0b013e3283390696.
2
Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.用抗原特异性凋亡小体脉冲处理的树突状细胞可预防实验性 1 型糖尿病。
Clin Exp Immunol. 2010 May;160(2):207-14. doi: 10.1111/j.1365-2249.2009.04082.x. Epub 2009 Dec 17.
3
Radiation induces an antitumour immune response to mouse melanoma.辐射诱导小鼠黑色素瘤的抗肿瘤免疫反应。
Int J Radiat Biol. 2009 Dec;85(12):1126-36. doi: 10.3109/09553000903242099.
4
Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway.钙网织蛋白募集到主要组织相容性复合体 I 组装途径的模式。
J Biol Chem. 2010 Feb 12;285(7):4520-35. doi: 10.1074/jbc.M109.085407. Epub 2009 Dec 3.
5
Chemotherapy induces ATP release from tumor cells.化疗会促使肿瘤细胞释放 ATP。
Cell Cycle. 2009 Nov 15;8(22):3723-8. doi: 10.4161/cc.8.22.10026. Epub 2009 Nov 8.
6
Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.自体黑色素瘤疫苗可诱导抗肿瘤和自身反应性免疫反应,这些反应会影响患者生存,且依赖于疫苗细胞上的MHC II类分子表达。
Clin Cancer Res. 2009 Aug 1;15(15):4968-77. doi: 10.1158/1078-0432.CCR-08-3320. Epub 2009 Jul 14.
7
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.以自更新、增殖的自体肿瘤细胞抗原负载树突状细胞作为转移性黑色素瘤患者的个体化抗肿瘤疫苗的II期试验:最终报告
Cancer Biother Radiopharm. 2009 Jun;24(3):311-9. doi: 10.1089/cbr.2008.0599.
8
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death.免疫原性细胞死亡中促凋亡钙网蛋白暴露的机制
EMBO J. 2009 Mar 4;28(5):578-90. doi: 10.1038/emboj.2009.1. Epub 2009 Jan 22.
9
Immunogenic cell death modalities and their impact on cancer treatment.免疫原性细胞死亡方式及其对癌症治疗的影响。
Apoptosis. 2009 Apr;14(4):364-75. doi: 10.1007/s10495-008-0303-9.
10
Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches.与其他方法相比,用经辐射的凋亡肿瘤细胞对树突状细胞进行抗原加载可诱导更强的抗肿瘤免疫力。
Cancer Immunol Immunother. 2009 Aug;58(8):1257-64. doi: 10.1007/s00262-008-0638-7. Epub 2009 Jan 13.